Figure 3 from Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers
Authors:
- Allison M. BarrettABAllison M. Barrett
- Zachary T. BrittonZBZachary T. Britton
- Rosa A. CarrascoRCRosa A. Carrasco
- Shannon BreenSBShannon Breen
- Maria A.S. BroggiMBMaria A.S. Broggi
- Amanda L. HatkeAHAmanda L. Hatke
- Benjamin ClarkBCBenjamin Clark
- Chunning YangCYChunning Yang
- Sandrina PhippsSPSandrina Phipps
- Lorenzo OrtizLOLorenzo Ortiz
- Brianna JanochaBJBrianna Janocha
- Peter ZanvitPZPeter Zanvit
Open Access
- 2 December 2024
- other
- Published by American Association for Cancer Research (AACR)